Cerenia
Loading...Cerenia Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
There is currently no usage information available for this product. We apologize for any inconvenience.
History
There is currently no drug history available for this drug.
Other Information
Maropitant is a neurokinin (NK1) receptor antagonist that blocks the pharmacological action of substance P in the central nervous system (CNS). Maropitant is the non-proprietary designation for a substituted quinuclidine. The empirical formula is C32H40N2O C6H8O7 H2O and the molecular weight 678.81. The chemical name is (2S,3S)-2- benzhydryl-N-(5-tert-butyl-2-methoxybenzyl) quinuclidin-3- amine citrate monohydrate. Each mL of CERENIA Injectable Solution contains 10 mg maropitant, 63 mg sulphobutylether-beta-cyclodextrin, 3.3 mg meta-cresol and water for injection.
The chemical structure of maropitant citrate is:
Sources
Cerenia Manufacturers
-
Pfizer Animal Health
![Cerenia (Maropitant Citrate) Injection, Solution [Pfizer Animal Health]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Cerenia | Pfizer Animal Health
Administer CERENIA Injectable Solution subcutaneously at 1 mg/kg (0.45 mg/lb) equal to 1 mL/10 kg (1 mL/22 lb) of body weight once daily for up to 5 consecutive days. Use of refrigerated product may reduce the pain response associated with the injection.
CERENIA Injectable Solution is recommended for use in dogs 8 weeks and older and cats 16 weeks and older.
Login To Your Free Account